A recent COVID-19 rapid test that received Food and Drug Administration (FDA) emergency use authorization includes technology invented by Rutgers University researchers, which will be used in about 50,000 tests produced per day by a global health care leader.

The molecular beacons technology provides powerful tools for imaging RNA in living cells and can determine if COVID-19 is present in a clinical sample.

The technology – invented and perfected by Rutgers scientists over the last decade, is being used as part of the Abbott Laboratories COVID-19 test. The test, which uses a nose swab and will be available around the country, takes less than 15 minutes to complete and can determine if the virus has invaded a cell, taken over its molecular machinery and is making new viruses.  To read the full article.